TrianglePUBLICATIONS · 35658469
Ciltacabtagene Autoleucel, an Anti-B-cell Maturation Antigen Chimeric Antigen Receptor T-Cell Therapy, for Relapsed/Refractory Multiple Myeloma: CARTITUDE-1 2-Year Follow-Up.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2023 Feb 20
- First author
- Martin T
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Martin T
- type
- Author
- name
- Usmani SZ
- type
- Author
- name
- Berdeja JG
- type
- Author
- name
- Agha M
- type
- Author
- name
- Cohen AD
- type
- Author
- name
- Hari P
- type
- Author
- name
- Avigan D
- type
- Author
- name
- Deol A
- type
- Author
- name
- Htut M
- type
- Author
- name
- Lesokhin A
- type
- Author
- name
- Munshi NC
- type
- Author
- name
- O'Donnell E
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Martin T
- type
- Author
- name
- Usmani SZ
- type
- Author
- name
- Berdeja JG
- type
- Author
- name
- Agha M
- type
- Author
- name
- Cohen AD
- type
- Author
- name
- Hari P
- type
- Author
- name
- Avigan D
- type
- Author
- name
- Deol A
- type
- Author
- name
- Htut M
- type
- Author
- name
- Lesokhin A
- type
- Author
- name
- Munshi NC
- type
- Author
- name
- O'Donnell E
- type
- Author
- bibliography ids
- nci-bib-ec9676cfb748e47cadb12428
- book metadata
- content sha256
- 444c836bc7560cad3867e908557dc5140be8849069a86ba28a6ca5de658efc42
- document type
- citation
- dois
- 10.1200/JCO.22.00842
- electronic publication date
- display
- 2022 Jun 4
- precision
- day
- year
- 2022
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:35658469
- immutable id
- pubmed:35658469@444c836bc7560cad3867e908557dc5140be8849069a86ba28a6ca5de658efc42
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 6
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 1265-1274
- volume
- 41
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 35658469
- provenance
- batch id
- 9d150d55960e0c12aada
- provider
- NCBI PubMed ESummary
- record sha256
- da06546123ea235d258cbfc40079786ad5aef6e90809a198b9fbd4133cab4339
- response sha256
- 2d4ef1cc8137eef6e7216f66bf8601c3899bc663b8626f412794d39585de6b6b
- retrieved at
- 2026-09-09T23:48:09.820498+00:00
- publication date
- display
- 2023 Feb 20
- precision
- day
- year
- 2023
- publication types
- Journal Article
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Ciltacabtagene Autoleucel, an Anti-B-cell Maturation Antigen Chimeric Antigen Receptor T-Cell Therapy, for Relapsed/Refractory Multiple Myeloma: CARTITUDE-1 2-Year Follow-Up.
Preserved source evidence · Not medical advice